Indication

Blepharoconjunctivitis

**Blepharoconjunctivitis** is an ophthalmic condition characterized by concurrent inflammation of the eyelid margins and the conjunctiva. Read more about Blepharoconjunctivitis

106 drugs 35 manufacturers

Advertisement

Drugs that treat it

Common Blepharoconjunctivitis therapies.

Showing 10–18 of 106 drugs

Filter & compare in the drug finder →Opens the drug finder with Blepharoconjunctivitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Blepharoconjunctivitis.

**Blepharoconjunctivitis** is an ophthalmic condition characterized by concurrent inflammation of the eyelid margins and the conjunctiva.

Affecting pediatric and adult populations, it often arises as an extension of anterior or posterior blepharitis—frequently driven by meibomian gland dysfunction, bacterial colonization (predominantly *Staphylococcus* species), viral infections, parasitic infestation, or allergic hypersensitivity.

This localized dysbiosis and inflammatory response disrupt tear film stability and epithelial integrity across the continuous ocular surface.

Defining clinical features include eyelid margin erythema, crusting or collarettes along the eyelashes, conjunctival hyperemia, ocular discharge, pruritus, burning, and a foreign body sensation, which may be complicated by secondary superficial keratitis.

Personalize your experience

Follow Blepharoconjunctivitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it